"PulmoTrack® has been approved by the US FDA and the Conformitée Européenne or European Conformity and Australian Therapeutic Goods Administration (TGA) for use as a respiratory acoustic monitor. The technology, on which the product is designed, is the result of extensive research and development that has run through various clinical trials worldwide, including the US, Europe, Australia, and Israel."
"The PulmoTrack® has received clearance by the Israeli Ministry of Health for sale in Israel • KarmelSonix (Israel) Ltd Quality System has received approval from the Canadian Standards Authority • Regulatory process continues in S. Korea (KFDA), China (SFDA), Australia (TGA for WheezoMeter) and Taiwan for Product Registration"
Asthma market $15billion
Cheers, The Sparkler
KSX Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
